CXCL10 and type 2 diabetes mellitus: Strikingly, what we found in the present study is that there is a significant number of patients with traditionally non-immune kidney diseases, such as hypertension and type 2 diabetes, that had elevated CXCL10, potentially indicating a broader utility in the detection of early-stage kidney injury.